Helix Biomedix Inc HXBM
Trading Information
- Previous Close Price
- $4.40
- Day Range
- $3.29–3.29
- 52-Week Range
- $1.00–6.50
- Bid/Ask
- $4.00 / $7.00
- Shares Outstanding
- 224,708.00
- Market Cap
- $739,289.32
- Volume/Avg
- 144 / 437
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Helix Biomedix Inc is a Delaware-based biopharmaceutical company that focuses on the early-stage development of peptide-based therapeutics for dermatology and skin health. The Company is in the preclinical stage, advancing a rare disease drug program for xeroderma pigmentosum, and plans to seek orphan drug designation before entering clinical development. Leveraging its proprietary peptide technology, Helix BioMedix aims to address unmet needs in rare dermatological conditions and has a history of developing patented bioactive peptides for topical personal care use.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8
- Website
- https://www.helixbiomedix.com
Valuation
|
Metric
|
HXBM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HXBM
|
|---|---|
Quick Ratio | 1.18 |
Current Ratio | 2.33 |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
HXBM
|
|---|---|
Return on Assets (Normalized) | −91.96% |
Return on Equity (Normalized) | −110.03% |
Return on Invested Capital (Normalized) | −110.08% |
Return on Assets
No chart available
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|fjdcvG | LOCK|L&l?H | $123B | |||
| Moderna Inc
MRNA
| LOCK|xFJd?#d | LOCK|>s! | $86B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|>xM#F?g | LOCK|>P!t | $78B | |||
| argenx SE ADR
ARGX
| LOCK|!swq!y< | LOCK|&cl | $50B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|VBz<Y?& | LOCK|Z# | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|DP&sn^ | LOCK|l%m@ | $30B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|!WTcS@V | LOCK|FZ^fD | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|W^<NQ% | LOCK|C# | $22B | |||
| Incyte Corp
INCY
| LOCK|%Rs!v@@ | LOCK|?< | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|x^n%kWs | LOCK|tDp | $14B |
United States